The tablets are indicated for smoking cessation and act as partial agonists of nicotinic acetylcholine receptors, helping ...

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Prucalopride Tablets, 1 mg and 2 mg (USRLD: Motegrity Tablets, 1 mg and 2 mg).

Ahmedabad: Zydus Lifesciences Limited has received NOC (Notice of Compliance) from Health Canada for ZDS-Varenicline tablets ...

Zydus Lifesciences receives NOC from Health Canada for ZDS-Varenicline tablets, a smoking cessation aid. Annual sales of ...

Zydus Lifesciences receives NOC for Varenicline tablets to aid in smoking cessation, with annual sales of CAD 15 million.

Zydus Lifesciences has secured a no objection certificate from Health Canada for its ZDS-Varenicline tablets, designed to aid ...

Ibrutinib is a kinase inhibitor indicated for the treatment of adult patients with chronic lymphocytic leukemia/small ...

While some sectors like smartphones, pharmaceuticals and energy are currently exempt from any reciprocal tariffs, other items ...

Blue Jet Healthcare promoter family buy three Worli luxury properties worth over ₹202 crore, signaling rising pharma wealth ...

Eris Lifesciences plans to lead in generic semaglutide drugs. The patent for Novo Nordisk's drug expires in India in March ...